3 Patents
- US124786742025Ipilimumab Variants with Enhanced Specificity for Binding at Low Ph
BRISTOL-MYERS SQUIBB COMPANY
0 cites - US120972412024Methods of Treating Kidney Failure, And/or Improving or Stablizing Renal Function Using Modified Relaxin Polypeptides
BRISTOL-MYERS SQUIBB COMPANY
0 cites - US120972422024Treatment of Fibrosis, Cardiovascular Disease and Heart Failure with Modified Relaxin Polypeptides
BRISTOL-MYERS SQUIBB COMPANY
0 cites